Search - tctmd.com

Displaying 1 - 20 of 84

Sort: Relevancy | Date

Presentation EuroPCR 2025

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

Presenter: Pierre Deharo

May 22, 2025

News Conference News EuroPCR 2025

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

L.A. McKeown

May 21, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

News Daily News

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Yael L. Maxwell

February 27, 2025

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

Presentation Miami Valves 2024

Critical Aortic Valve Stenosis of Severely Calcific Bicuspid Valve with Acute Cardiogenic Shock

Presenter: Victor Razuk

February 01, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Conference News EuroPCR 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

Caitlin E. Cox

May 16, 2023

News Daily News

Soft Robotics Approach Brings Hemodynamics to 3D Aortic Models

Yael L. Maxwell

March 03, 2023

News Daily News

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

Todd Neale

January 20, 2023

Advertisement

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

Myval Noninferior to Other THVs at 1 Year, but Questions Persist

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Pi-Cardia Reports First Commercial Cases with ShortCut™

Ataciguat Shows Potential for Curbing Progression of Aortic Stenosis

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Pi-Cardia Receives FDA Market Clearance for ShortCut™

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Critical Aortic Valve Stenosis of Severely Calcific Bicuspid Valve with Acute Cardiogenic Shock

TAVI, SAVR Almost Equally Performed in California Patients Under 60

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

Soft Robotics Approach Brings Hemodynamics to 3D Aortic Models

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content